THE USE OF ROMIPLOSTIM IN AN INFANT
Case report: Immune thrombocytopenia (ITP) is the most common platelet disorder in children, peaking between the ages of 1-7.The first line therapy consists of intravenous immunoglobulin, anti-D immunoglobulin or corticosteroids. Second-line treatment options are immunosuppressive therapy, Rituximab...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e532f33be60f441e91ddee70a06808f3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|